Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2018Blood AdvancesOpen Access

Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists

View Full Paper
Ask AI
Bookmark
Share

Authors

CPChristopher T. PetersenSt. Jude Children's Research HospitalMHMojibade HassanUniversity of FloridaAMAnna B. MorrisEmory Healthcare

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Petersen et al. (2018) studied this question.

synapsesocial.com/papers/6a001044f9353b931b7744ffhttps://doi.org/10.1182/bloodadvances.2017011254
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of mouse T‐cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL‐2 production and cAMP synthesis1991 · 110 citations
  2. 2Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people2008 · 379 citations
  3. 3T Cell Anergy2003 · 1,488 citations